A new BAPP bulletin disseminates ways to detect the adulteration of ashwagandha products with undeclared material taken from the leaves or the stems of the plant.
Gencor Pacific hopes to introduce a new supplement and functional food category with Slimaluma, its brand of Caralluma fimbriata extract (CFE), after the first human RCT on the product's anti-stress effects reported positive results.
DSM Hydrocolloids, the specialty hydrocolloids arm of Royal DSM, has unveiled new branding for its gellan gum and xanthan gum portfolios, with the firm targeting new opportunities in ‘cross-segment’ applications.
OptiBiotix Health has entered a manufacturing and supply deal with Zeon Lifesciences, in which the two firms will share profits of Optibiotix’s microbiome-based weight management technology.
Chinese/American company Lyxia has debuted as a new player in the algae omega-3s space with a highly refined EPA ingredient from a photosynthetic strain.
A combination of DuPont’s Howaru Shape probiotic and Litesse Ultra prebiotic may beneficially alter the gut microbiota and improve gut barrier function, says a new study from DuPont Nutrition & Health.
Taiwanese probiotics firm Synbio Tech is aiming for a strong entry into the US sports nutrition market with a probiotic strain capable of building muscle mass.
Pharmako Biotechnologies has had the patent for its LipiSperse technology approved by the World Intellectual Property Organization (WIPO), opening the door for the firm to develop novel formulations for lipid-soluble compounds.
Royal DSM has reopened its Jiangshan vitamin C plant after extensive upgrades, and has signed an agreement with local authorities to transition from coal to natural gas power within three years.
Norwegian firm Kappa Bioscience recently received approval for a drug import licence to India for its proprietary vitamin K2 ingredient, K2VITAL DELTA — the first such licence of its kind.
